This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.82% per year. These returns cover a period from January 1, 1988 through October 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
multi-sector-conglomerates: Archive
Top Research Reports for Mastercard, AstraZeneca & Sandisk
by Mark Vickery
Mastercard's payment growth, AstraZeneca's drug pipeline and Sandisk's AI-driven SSD demand headline today's top research reports, revealing key growth drivers and risks for investors.
AZNPositive Net Change MANegative Net Change SNDKNegative Net Change EXCPositive Net Change GISPositive Net Change HALOPositive Net Change
business-services computers medical multi-sector-conglomerates
Zacks Initiates Coverage of LIVE With Neutral Recommendation
by Urbashi Dutta
Discover why Zacks, being the first on Wall Street to initiate stock coverage, rates Live Ventures as "Neutral." Explore how LIVE balances improving steel profitability and margin expansion against flooring weakness, debt pressures and financial risks.
LIVEPositive Net Change
multi-sector-conglomerates
3M's Margins Improve Amid Cost Pressures: Can the Trend Continue?
by Zacks Equity Research
MMM margin gains reflect restructuring, productivity improvements and AI-driven transformation, but rising tariffs, oil prices and other costs threaten to derail momentum.
MMMPositive Net Change HONPositive Net Change CSLNegative Net Change
multi-sector-conglomerates
Carlisle Exhibits Strong Prospects Despite Persisting Headwinds
by Zacks Equity Research
CSL's segments deliver strong revenue growth, while acquisitions and shareholder returns support expansion despite rising raw-material costs and margin pressures.
CSLNegative Net Change MMMPositive Net Change GFFNegative Net Change GPGINegative Net Change
multi-sector-conglomerates
Will MMM's Safety & Industrial Segment Remain a Core Strength in 2026?
by Zacks Equity Research
3M's Safety and Industrial segment stays strong on broad-based demand, rising sales and productivity gains, supporting an upbeat 2026 outlook.
MMMPositive Net Change HONPositive Net Change CSLNegative Net Change
multi-sector-conglomerates
Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?
by Sundeep Ganoria
MRNA's Nasdaq-100 entry follows a 566% stock surge and stronger cancer therapy prospects, potentially boosting demand from index-tracking funds.
MRNAPositive Net Change MRKPositive Net Change SKYDNegative Net Change
biotechs internet medical multi-sector-conglomerates pharmaceuticals vaccines
Here's Why It is Appropriate to Invest in ITT Stock Right Now
by Zacks Equity Research
ITT's segment strength, accretive acquisitions, innovation and shareholder rewards position it for near-term growth.
ITTNegative Net Change MMMPositive Net Change GFFNegative Net Change GPGINegative Net Change
multi-sector-conglomerates
INNOVATE Completes DBM Global Sale, Targets Debt Reduction
by Urbashi Dutta
VATE completes the DBM Global sale for about $413 million in cash plus IES shares, with net proceeds earmarked to reduce debt and boost flexibility.
IESCNegative Net Change VATENegative Net Change
multi-sector-conglomerates
3M Rises 12.9% in the Past Six Months: Is There Still Room to Grow?
by Susmita Roy
MMM's growth is supported by strong industrial and electronics demand, restructuring and acquisitions, but consumer weakness and valuation remain concerns.
MMMPositive Net Change CSLNegative Net Change GFFNegative Net Change
multi-sector-conglomerates
3 Dividend-Paying ADRs to Consider for Portfolio Diversification
by Shaun Pruitt
Aperam, ASX Limited, and Grupo Cibest offer three very different ways to diversify beyond U.S. equities while collecting dividend yields above 3%.
ASXFYNegative Net Change CIBPositive Net Change APEMYNegative Net Change
basic-materials dividend-investing dividends finance investing multi-sector-conglomerates